Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Innis

Showing results (71-80 of 133) with videos related to

Pageof 14
Sort By:
The American Journal of Psychiatry|September 29, 2000
Prediction of dopamine transporter binding availability by genotype: a preliminary reportL K Jacobsen, J K Staley, S S Zoghbi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 2000
Behavioral changes and [123I]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamineS A Castner, M S al-Tikriti, R M Baldwin, et al.
Nuclear Medicine and Biology|April 1, 1997
Radiosynthesis and PET imaging of [N-methyl-11C]LY257327 as a tracer for 5-HT transportersY Zea-Ponce, R M Baldwin, M D Stratton, et al.
Journal of Neurochemistry|March 1, 1994
Methyl 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditionsM Laruelle, S S Giddings, Y Zea-Ponce, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 20, 2000
Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECTM Fujita, G Tamagnan, S S Zoghbi, et al.
The American Journal of Psychiatry|June 30, 2000
Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patientsL K Jacobsen, J K Staley, R T Malison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patientsJ P Seibyl, K Marek, K Sheff, et al.
Experimental Neurology|April 1, 1994
Novel radioligands for the dopamine transporter demonstrate the presence of intrastriatal nigral grafts in the MPTP-treated monkey: correlation with improved behavioral functionJ D Elsworth, M S al-Tikriti, J R Sladek, et al.
Synapse (New York, N.Y.)|August 9, 2001
Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokersJ K Staley, S Krishnan-Sarin, S Zoghbi, et al.
Nuclear Medicine and Biology|December 10, 1999
Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodentP Z Tan, R M Baldwin, C H Van Dyck, et al.
Pageof 14

Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
The American Journal of Psychiatry|September 29, 2000
Prediction of dopamine transporter binding availability by genotype: a preliminary reportL K Jacobsen, J K Staley, S S Zoghbi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 2000
Behavioral changes and [123I]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamineS A Castner, M S al-Tikriti, R M Baldwin, et al.
Nuclear Medicine and Biology|April 1, 1997
Radiosynthesis and PET imaging of [N-methyl-11C]LY257327 as a tracer for 5-HT transportersY Zea-Ponce, R M Baldwin, M D Stratton, et al.
Journal of Neurochemistry|March 1, 1994
Methyl 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditionsM Laruelle, S S Giddings, Y Zea-Ponce, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 20, 2000
Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECTM Fujita, G Tamagnan, S S Zoghbi, et al.
The American Journal of Psychiatry|June 30, 2000
Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patientsL K Jacobsen, J K Staley, R T Malison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patientsJ P Seibyl, K Marek, K Sheff, et al.
Experimental Neurology|April 1, 1994
Novel radioligands for the dopamine transporter demonstrate the presence of intrastriatal nigral grafts in the MPTP-treated monkey: correlation with improved behavioral functionJ D Elsworth, M S al-Tikriti, J R Sladek, et al.
Synapse (New York, N.Y.)|August 9, 2001
Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokersJ K Staley, S Krishnan-Sarin, S Zoghbi, et al.
Nuclear Medicine and Biology|December 10, 1999
Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodentP Z Tan, R M Baldwin, C H Van Dyck, et al.
Pageof 14